Semaglutide

🧬 

Semaglutide (GLP-1 Receptor Agonist Peptide)

Category: Metabolic & Obesity Research

Purity: ≥ 99% (Research Grade)

🔬 

Research Overview

Semaglutide is a long-acting GLP-1 receptor agonist peptide that mimics the natural incretin hormone responsible for regulating appetite, glucose metabolism, and insulin release.

It is widely studied for its potential to improve body composition, glycemic control, and metabolic performance by influencing both energy intake and energy expenditure.

⚙️ 

Key Research Highlights

• Supports fat reduction and may help preserve lean muscle mass
• Promotes balanced glucose levels and enhanced insulin sensitivity
• May reduce appetite and improve satiety signaling
• Shows potential to lower blood pressure and lipids in ongoing studies
• Demonstrates cardiometabolic benefits in long-term research

⚠️ 

Disclaimer

This compound is supplied for laboratory and educational research only.

Not for human consumption, injection, or diagnostic use.

Semaglutide remains investigational and not approved by the FDA.